Literature DB >> 16129871

Metformin's contraindications should be contraindicated.

James McCormack1, Kevin Johns, Hugh Tildesley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16129871      PMCID： PMC1188187          DOI： 10.1503/cmaj.045292

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  22 in total

1.  Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

Authors:  M Hanefeld; M Cagatay; T Petrowitsch; D Neuser; D Petzinna; M Rupp
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

2.  No evidence for a reduction of myocardial infarctions by acarbose.

Authors:  Floris A van de Laar; Peter L B J Lucassen
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

3.  Lactic acidosis in patients with diabetes treated with metformin.

Authors:  R I Misbin; L Green; B V Stadel; J L Gueriguian; A Gubbi; G A Fleming
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

4.  Metformin-induced lactic acidosis in the presence of acute renal failure.

Authors:  R Assan; C Heuclin; D Ganeval; C Bismuth; J George; J R Girard
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

5.  Contraindications to metformin therapy in patients with NIDDM.

Authors:  T V Sulkin; D Bosman; A J Krentz
Journal:  Diabetes Care       Date:  1997-06       Impact factor: 19.112

6.  Role of metformin accumulation in metformin-associated lactic acidosis.

Authors:  J D Lalau; C Lacroix; P Compagnon; B de Cagny; J P Rigaud; G Bleichner; P Chauveau; P Dulbecco; C Guérin; J M Haegy
Journal:  Diabetes Care       Date:  1995-06       Impact factor: 19.112

Review 7.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Arch Intern Med       Date:  2003-11-24

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.

Authors:  A K Waters; D B Morgan; J K Wales
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122
View more
  17 in total

1.  Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.

Authors:  Savas Sipahi; Yalcin Solak; Seyyid Bilal Acikgoz; Ahmed Bilal Genc; Mehmet Yildirim; Ulku Yilmaz; Ahmet Nalbant; Ali Tamer
Journal:  Int Urol Nephrol       Date:  2016-04-21       Impact factor: 2.370

Review 2.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

3.  [Female patient with type 2 diabetes in coma with metabolic acidosis].

Authors:  T zur Nieden; T Conrad
Journal:  Internist (Berl)       Date:  2009-11       Impact factor: 0.743

Review 4.  Metformin: effective and safe in renal disease?

Authors:  William Guy Herrington; Jeremy B Levy
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.

Authors:  C Agard; M Rolli-Derkinderen; E Dumas-de-La-Roque; M Rio; C Sagan; J P Savineau; G Loirand; P Pacaud
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

6.  Use of Renally Inappropriate Medications in Older Veterans: A National Study.

Authors:  Flora Chang; Ann M O'Hare; Yinghui Miao; Michael A Steinman
Journal:  J Am Geriatr Soc       Date:  2015-10-27       Impact factor: 5.562

Review 7.  Use of metformin in the setting of mild-to-moderate renal insufficiency.

Authors:  Kasia J Lipska; Clifford J Bailey; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

8.  Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality.

Authors:  Dean T Eurich; Ross T Tsuyuki; Sumit R Majumdar; Finlay A McAlister; Richard Lewanczuk; Marcelo C Shibata; Jeffrey A Johnson
Journal:  Trials       Date:  2009-02-09       Impact factor: 2.279

9.  Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Authors:  Katy E Trinkley; Heather D Anderson; Kavita V Nair; Daniel C Malone; Joseph J Saseen
Journal:  Ther Adv Chronic Dis       Date:  2018-06-13       Impact factor: 5.091

10.  Metformin and the promise of geroprotection.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.